<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-140466" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Indocyanine Green (ICG) Angiography</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Muraleedharan</surname>
            <given-names>Sabareesh</given-names>
          </name>
          <aff>Aravind Eye Hospital, Madurai, India</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tripathy</surname>
            <given-names>Koushik</given-names>
          </name>
          <aff>ASG Eye Hospital, BT Road, Kolkata, India</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sabareesh Muraleedharan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Koushik Tripathy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-140466.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Indocyanine green angiography is an important invasive imaging modality among many diagnostic imaging modalities used in retinochoroidal diseases. It helps to study the anatomy, physiology, and pathology of choroidal and retinal circulation. It has an important role in the diagnosis of various ocular pathologies. This activity describes the anatomy of choroidal circulation and reviews the techniques and interpretation of indocyanine green angiography. It also highlights the role of the interprofessional team in monitoring the patient and managing adverse events during the procedure.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the anatomy and physiology of choroidal circulation.</p></list-item><list-item><p>Review the personnel, equipment, preparation, and technique of indocyanine green angiography.</p></list-item><list-item><p>Outline the characteristics of various retinal and choroidal diseases on an indocyanine green angiogram.</p></list-item><list-item><p>Explain the importance of the availability of an interprofessional team for monitoring the patient and managing complications during indocyanine green angiography.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140466&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140466">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-140466.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Indocyanine green angiography (ICGA) is used to image the choroidal circulation and its abnormalities.<xref ref-type="bibr" rid="article-140466.r1">[1]</xref>&#x000a0;Even though fundus fluorescein angiography (FFA) is a good tool for imaging retinal circulation in great detail, its ability to image the choroidal circulation is limited by the poor transmission of fluorescence through retinal pigment epithelium (RPE), media opacities, and retinal exudates.<xref ref-type="bibr" rid="article-140466.r2">[2]</xref> The physical characteristics of indocyanine green (ICG) allow its visualization through RPE, lipid exudates, and serosanguineous fluid. Indocyanine green has an absorption&#x000a0;peak at 790&#x000a0;to 805 nm and a peak emission spectrum at 835 nm.<xref ref-type="bibr" rid="article-140466.r3">[3]</xref></p>
        <p>As its absorption and emission spectrum is of a higher wavelength than that of fluorescein, the infrared rays to and from ICG can penetrate better through the RPE, macular xanthophyll pigments, and media opacities. Also, 98% of ICG in serum is protein-bound, allowing only limited diffusion through the fenestrations of the choriocapillaris, whereas FA diffuses quickly, blurring the anatomy of the choroid.<xref ref-type="bibr" rid="article-140466.r4">[4]</xref><xref ref-type="bibr" rid="article-140466.r5">[5]</xref></p>
        <p>ICG was approved for human use by Food and Drug Administration (FDA), the USA, in 1956.<xref ref-type="bibr" rid="article-140466.r6">[6]</xref>&#x000a0;ICG angiography (ICGA) of the human choroid was first performed by R W Flower in 1972.<xref ref-type="bibr" rid="article-140466.r7">[7]</xref>&#x000a0;Initially, the clarity of images was poor as the ICG molecule has poor fluorescence efficiency compared to FA. But, technological advances in imaging systems (scanning laser ophthalmoscope or SL- based systems) led to the development of high-resolution cameras that could capture ICGA images with great clarity. In the era of anti-vascular endothelial growth factor (anti-VEGF) agents and optical coherence tomography (OCT), the&#x000a0;monitoring of the choroidal neovascular membrane (CNVM) has become easier.<xref ref-type="bibr" rid="article-140466.r8">[8]</xref><xref ref-type="bibr" rid="article-140466.r9">[9]</xref></p>
        <p>Still, ICGA continues to be an important imaging modality in clinical practice in evaluating various disorders, including&#x000a0;idiopathic polypoidal choroidal vasculopathy (IPCV), retinal angiomatous proliferation (RAP), central serous chorioretinopathy (CSCR),&#x000a0;ocular inflammatory conditions including sympathetic ophthalmia (SO)&#x000a0;and Vogt Koyanagi Harada syndrome (VKH); and ocular tumors.<xref ref-type="bibr" rid="article-140466.r10">[10]</xref><xref ref-type="bibr" rid="article-140466.r11">[11]</xref></p>
      </sec>
      <sec id="article-140466.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>The blood supply of the choroid is from the ophthalmic artery, the first branch of the internal carotid artery.<xref ref-type="bibr" rid="article-140466.r12">[12]</xref>&#x000a0;The medial and lateral posterior ciliary arteries (PCAs) arise from the ophthalmic artery, which&#x000a0;continues as long PCAs&#x000a0;after giving 10 to 20 short PCAs. The short PCAs pierce the sclera near the optic nerve and supply the choroid, whereas the two long ciliary arteries pierce the sclera further away from the optic nerve and run in the suprachoroidal space anteriorly. The short PCAs supply the posterior part of the choroid extending from the posterior pole to the equator. The long PCAs supply whole of the choroid anterior to the equator and a small portion posterior to the equator. The PCAs behave as end arteries and do not anastomose with each other. This leads to the formation of the choroidal watershed zones.<xref ref-type="bibr" rid="article-140466.r13">[13]</xref></p>
        <p>The innermost layer of the choroid is Bruch membrane. The Bruch membrane is composed of five sublayers- the basement membrane of retinal pigment epithelium, the inner collagenous layer, the middle elastic layer, the outer collagenous layer, and the basement membrane of choriocapillaris. Outside the Bruch membrane, there are three vascular layers- the inner choriocapillaris composed of a highly anastomosed capillary network, the middle Sattler layer formed by medium-sized arterioles, and the outer layer of larger arterioles, the Haller layer.<xref ref-type="bibr" rid="article-140466.r14">[14]</xref>&#x000a0;The choriocapillaris lobule is the functional unit of choroidal circulation that is functionally independent.<xref ref-type="bibr" rid="article-140466.r15">[15]</xref>&#x000a0;</p>
        <p>The functional lobules are more evident during the filling and draining phases of the fluorescein angiogram.<xref ref-type="bibr" rid="article-140466.r16">[16]</xref>&#x000a0;A terminal choroidal arteriole supplies each choriocapillaris lobule. There is no anastomosis with the adjacent choriocapillaris lobule. The blood from the choroidal circulation is drained through the vortex veins. The venous system also has segmental distribution. There is no anastomosis between the veins draining to each vortex vein.<xref ref-type="bibr" rid="article-140466.r17">[17]</xref></p>
        <p>The blood supply to the choroid is probably the highest among any tissue in the human body per unit of tissue weight. It is ten times higher than that of the brain. This extremely high blood flow helps maintain higher oxygen tension in the choroid than in the retina. This helps in the diffusion of oxygen from the choroid to the retina. The choroidal circulation is the major supply of oxygen to the retina. During the dark, when the photoreceptors are highly metabolically active, up to 90% of the blood supply to the retina is from the choroidal circulation. The walls of the choriocapillaris are fenestrated, which allows high permeability of glucose and other small molecules.<xref ref-type="bibr" rid="article-140466.r18">[18]</xref>&#x000a0;</p>
        <p>But larger proteins are not permeable through the fenestrations. ICG&#x000a0; is 98% protein-bound making it largely impermeable through the choriocapillaris wall.<xref ref-type="bibr" rid="article-140466.r4">[4]</xref>&#x000a0;On&#x000a0;the contrary, fluorescein is only 80% protein bound.<xref ref-type="bibr" rid="article-140466.r19">[19]</xref>&#x000a0;So it readily diffuses out of the choriocapillaris.<xref ref-type="bibr" rid="article-140466.r20">[20]</xref></p>
      </sec>
      <sec id="article-140466.s4" sec-type="Indications">
        <title>Indications</title>
        <p>The indications of ICGA include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Exudative age-related macular degeneration (wet AMD)<xref ref-type="bibr" rid="article-140466.r21">[21]</xref></p>
          </list-item>
          <list-item>
            <p>Idiopathic polypoidal choroidal vasculopathy (IPCV or PCV)<xref ref-type="bibr" rid="article-140466.r22">[22]</xref></p>
          </list-item>
          <list-item>
            <p>Retinal angiomatous proliferation (RAP)<xref ref-type="bibr" rid="article-140466.r23">[23]</xref></p>
          </list-item>
          <list-item>
            <p>Central serous chorioretinopathy (CSCR)<xref ref-type="bibr" rid="article-140466.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Retinal arterial macroaneurysm (RAM)<xref ref-type="bibr" rid="article-140466.r24">[24]</xref></p>
          </list-item>
          <list-item>
            <p>Choroidal tumors
<list list-type="bullet"><list-item><p>Choroidal melanoma</p></list-item><list-item><p>Choroidal hemangioma</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>White Dot Syndromes<xref ref-type="bibr" rid="article-140466.r25">[25]</xref>
<list list-type="bullet"><list-item><p>Birdshot chorioretinopathy (BSCR)</p></list-item><list-item><p>Multifocal choroiditis</p></list-item><list-item><p>Multiple evanescent white dot syndrome (MEWDS)</p></list-item><list-item><p>Serpiginous choroidopathy</p></list-item><list-item><p>Acute posterior multifocal placoid pigment epitheliopathy (APMPPE)</p></list-item><list-item><p>Punctate inner chorioretinopathy (PIC)</p></list-item><list-item><p>Acute zonal occult outer retinopathy (AZOOR)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Chorioretinal atrophy</p>
          </list-item>
          <list-item>
            <p>Ocular inflammatory diseases
<list list-type="bullet"><list-item><p>Sympathetic ophthalmia (SO)<xref ref-type="bibr" rid="article-140466.r26">[26]</xref></p></list-item><list-item><p>Vogt Koyanagi Harada syndrome (VKH)<xref ref-type="bibr" rid="article-140466.r27">[27]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
        <p>ICG is also used to determine liver function, hepatic blood flow, and cardiac output. ICGA has been used intraoperatively during the surgical management of intracranial aneurysms.<xref ref-type="bibr" rid="article-140466.r28">[28]</xref><xref ref-type="bibr" rid="article-140466.r29">[29]</xref></p>
      </sec>
      <sec id="article-140466.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>ICG is a relatively safe and well-tolerated dye. It has only a few contraindications in ophthalmological use. In patients who are allergic to iodide or shellfish, ICGA should not be performed. Also, it is contraindicated in patients with uremia and those with a history of severe hypersensitivity.<xref ref-type="bibr" rid="article-140466.r30">[30]</xref>&#x000a0;</p>
        <p>ICG is exclusively eliminated through the liver. So in patients with liver disease, ICGA is not recommended.<xref ref-type="bibr" rid="article-140466.r31">[31]</xref>&#x000a0;According to FDA classification, ICG is a pregnancy category C drug. That means there are no adequate studies on humans to establish safety.<xref ref-type="bibr" rid="article-140466.r32">[32]</xref>&#x000a0;The aqueous solution of ICG has to be used within 6 hours. An interval of at least one week is necessary after ICGA for radioactive iodine uptake studies.</p>
      </sec>
      <sec id="article-140466.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>A fundus camera&#x000a0;with excitation and a barrier filter is&#x000a0;used for taking photographs. There are two categories of fundus cameras used for ICGA, digital flash cameras and confocal scanning laser ophthalmoscopes (SLOs). In a digital flash camera (including FF 450 plus by Zeiss and TRC-50DX by Topcon), the light source is white light. Its excitation filter transmits rays of wavelength between 640&#x000a0;and 780 nm and barrier filter between 820&#x000a0;and 900 nm. In SLOs (including Spectralis by Heidelberg, Mirante by Nidek, and California by Optos), laser monochromatic light is used for excitation. The Spectralis uses a diode laser (790 nm) for excitation.<xref ref-type="bibr" rid="article-140466.r33">[33]</xref> A barrier filter of 830 nm is used in Spectralis. Dynamic ICGA is possible in the SLO system as it can capture 12&#x000a0;to 15 images per second.<xref ref-type="bibr" rid="article-140466.r34">[34]</xref></p>
        <p>The standard intravenous dose of ICG for an adult individual is 25 mg in 5 ml solvent.<xref ref-type="bibr" rid="article-140466.r35">[35]</xref>&#x000a0;A&#x000a0;23 gauge scalp vein needle set, a 5 ml syringe with a needle, alcohol swab, tourniquet, and armrest&#x000a0;are also required. A standard emergency&#x000a0;kit for the management of anaphylaxis should always be kept ready before starting the procedure.</p>
      </sec>
      <sec id="article-140466.s7" sec-type="Personnel">
        <title>Personnel</title>
        <p>The&#x000a0;team of health care workers for carrying out&#x000a0;ICGA includes an ophthalmologist, technician, optometrist, a nursing staff, and an anesthetist.</p>
      </sec>
      <sec id="article-140466.s8" sec-type="Preparation">
        <title>Preparation</title>
        <p>Informed consent should be taken from the patient before starting the procedure. The risks and benefits of the procedure should be explained to the patient. A thorough history of the allergies and systemic comorbidities of the patient should be taken&#x02014;two to four hours of fasting before the procedure are&#x000a0;recommended. The adult dose of ICG is 25 mg in 5 ml of solvent. If SLO systems are used, 25 mg of ICG is dissolved in 3 ml of solvent, and only 1 ml of solution is injected. A 5 ml saline flush should be given immediately after injecting the dye.&#x000a0;</p>
        <p>It should be made sure that pupils are well dilated before starting the procedure. The emergency&#x000a0;kit should be available. A&#x000a0;few&#x000a0;color fundus&#x000a0;images should be taken to check for clarity and focus. The patient should be comfortably seated, and the arm should be placed on the armrest. The chin should be&#x000a0;kept&#x000a0;on the chinrest. The patient should understand that the images will be taken&#x000a0;first in the&#x000a0;primary gaze and&#x000a0;later in different gazes. The scalp vein set is inserted into a vein in the ventral aspect of the forearm. It is important to ensure that the needle is inside the vein by drawing some blood or flushing with saline.</p>
      </sec>
      <sec id="article-140466.s9" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>After placing the patient's chin on the chin rest, the assistant holds the head of the patient to prevent head movements while capturing images. The moment dye is injected, control photographs are taken, which automatically switches on the timer. Pictures are taken at an interval of 1.5&#x000a0;to 2 seconds.&#x000a0;After the choroidal arterial and venous system is filled with the dye, photographs are taken at a slower pace. Pictures of the fellow eye also have to be taken.&#x000a0;</p>
        <p>
<bold>Normal ICGA Phases</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>&#x000a0;Early phase - The early phase has three stages:
<list list-type="order"><list-item><p>Stage 1: Begins 2 seconds after the injection of the dye. It is marked by rapid filling of choroidal arteries and choriocapillaris and early filling of choroidal veins. The choroidal watershed zone and the retinal vasculature remain dark in this stage.&#x000a0;</p></list-item><list-item><p>Stage 2: Three to five seconds after ICG injection, larger choroidal veins, and retinal arterioles fill the dye.</p></list-item><list-item><p>Stage 3: (6 seconds to 3 minutes) - The choroidal watershed zone gets filled with the dye, and larger choroidal veins and choroidal arteries begin to fade.&#x000a0;</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>The middle phase (3 to 15 minutes) is characterized by fading of the retinal and choroidal vessels.</p>
          </list-item>
          <list-item>
            <p>Late phase (15 to 60 minutes) - Staining of the extrachoroidal tissue is noted. It gives an illusion that choroidal vasculature is hypofluorescent compared to the background tissue. Retinal vessels are not visualized during this phase.<xref ref-type="bibr" rid="article-140466.r3">[3]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-140466.s10" sec-type="Complications">
        <title>Complications</title>
        <p><xref ref-type="bibr" rid="article-140466.r36">[36]</xref>Adverse effects of ICGA are less common compared to FA. Extravasation of the dye can cause a stinging sensation. Mild side effects like nausea and vomiting are seen in 0.15% of patients. Moderate adverse events like urticaria, vasovagal events are seen in 0.2% of patients. Urticaria can be treated using antihistamines. The incidence of severe adverse events is 0.05%. Anaphylaxis can occur in patients with iodine allergies. The incidence of adverse events is more common in patients with uremia compared to the general population.<xref ref-type="bibr" rid="article-140466.r37">[37]</xref></p>
      </sec>
      <sec id="article-140466.s11" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>Exudative Age-Related Macular Degeneration (exudative AMD or wet AMD)</bold>
</p>
        <p>ICGA helps to delineate the extent of occult CNVM.&#x000a0;Occult CNVM comprises 60-85% of CNV in wet AMD.<xref ref-type="bibr" rid="article-140466.r38">[38]</xref><xref ref-type="bibr" rid="article-140466.r39">[39]</xref>&#x000a0;In ICGA, three morphologic variants of CNVM have been described: hot spot or focal spot, plaque (poorly defined or well defined), and mixed or combined (both hot spot and plaque are present).<xref ref-type="bibr" rid="article-140466.r35">[35]</xref>&#x000a0;</p>
        <p>The combined type of CNVM may have a hot spot or multiple hot spots at the edge of the plaque (marginal hot spots), hot spots over the plaque (overlying hot spots), or hot spots away from the plaque (remote spots).&#x000a0;In eyes with occult CNVM, a majority (around 60%) of eyes reveal plaques on ICGA, and approximately 30% of eyes show hot spots. The rest of the eyes have combined lesions.&#x000a0;The visual prognosis&#x000a0;of plaque may be worse compared to hot spots, and hot spots may be treated easily with PDT.<xref ref-type="bibr" rid="article-140466.r40">[40]</xref>&#x000a0;</p>
        <p>ICGA helps determine the presence of CNVM in a retinal pigment epithelial detachment (PED). In a PED without CNVM (non-vascularized PED), hypocyanescence is noted throughout the phases of ICGA.&#x000a0;In eyes with proven occult CNVM with serous PED (vascularized PED) on FFA, 62% showed plaque (size more than one disc area), 38% of eyes showed focal CNVM (with a maximum size of one optic disc area), and in 4% of eyes ICGA could not detect a CNVM.<xref ref-type="bibr" rid="article-140466.r41">[41]</xref>&#x000a0;Vascularized PEDs&#x000a0;may show a notch at the margin, which may suggest the area of CNVM on FFA as described by Gass.<xref ref-type="bibr" rid="article-140466.r42">[42]</xref>&#x000a0;</p>
        <p>Advantages of ICGA include the ability to visualize CNVM or other causes of subretinal or submacular hemorrhage.&#x000a0;The causes of submacular hemorrhage, as revealed by ICGA in a study on 51 eyes, included wet AMD (around 53%), PCV (about 37%), retinal arterial macroaneurysm (about 6%), and lacquer cracks.<xref ref-type="bibr" rid="article-140466.r43">[43]</xref>&#x000a0;ICGA is usually not used to study classic CNVM on FFA as it may not provide clinically relevant additional information.</p>
        <p>Clear lesion delineation is crucial in treatment modalities like photodynamic therapy (PDT) and laser photocoagulation.&#x000a0;Anti-VEGF therapy causes regression of only immature vessels. It does not affect mature vessels.<xref ref-type="bibr" rid="article-140466.r44">[44]</xref> ICGA helps in differentiating immature and mature vessels. This may be of great help, especially in non-regressed CNVMs after multiple anti-VEGF injections.&#x000a0;</p>
        <p>
<bold>Retinal angiomatous proliferation (RAP) or Type 3 CNVM</bold>
</p>
        <p>RAP may contribute to up to 20% of cases of wet AMD.&#x000a0;ICGA also aids in&#x000a0;differentiating occult CNVM from retinal angiomatous proliferation (RAP). The feeding retinal arteriole and the draining retinal venule in RAP can be visualized in ICGA.<xref ref-type="bibr" rid="article-140466.r45">[45]</xref>&#x000a0;Typical features of RAP include intraretinal hemorrhage, retino-retinal anastomosis visible in the early phase of ICGA, high-flow vascular alterations, retino-choroidal anastomosis, and double retinal and choroidal circulation.<xref ref-type="bibr" rid="article-140466.r46">[46]</xref><xref ref-type="bibr" rid="article-140466.r47">[47]</xref></p>
        <p>Cystoid macular edema and PED may be associated.<xref ref-type="bibr" rid="article-140466.r48">[48]</xref> RAP is associated with a poor functional prognosis unless treated&#x000a0;at&#x000a0;an early stage.<xref ref-type="bibr" rid="article-140466.r49">[49]</xref>&#x000a0;Also, the treatment response of RAP is better with combined anti-VEGF and photodynamic therapy compared to anti-VEGF alone.<xref ref-type="bibr" rid="article-140466.r50">[50]</xref><xref ref-type="bibr" rid="article-140466.r51">[51]</xref></p>
        <p>
<bold>Polypoidal Choroidal vasculopathy (PCV)</bold>
</p>
        <p>ICGA is highly recommended for identifying PCV lesions, and ICGA is considered the gold standard for diagnosing PCV.<xref ref-type="bibr" rid="article-140466.r35">[35]</xref><xref ref-type="bibr" rid="article-140466.r52">[52]</xref>&#x000a0;ICGA should be advised to rule out PCV in the eyes with:</p>
        <list list-type="bullet">
          <list-item>
            <p>Massive spontaneous subretinal or submacular hemorrhage</p>
          </list-item>
          <list-item>
            <p>Orange-red subretinal nodule</p>
          </list-item>
          <list-item>
            <p>Notched or hemorrhagic PED, and&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Poor response to anti-VEGF therapy.<xref ref-type="bibr" rid="article-140466.r52">[52]</xref></p>
          </list-item>
        </list>
        <p>PCV is an abnormality of choroidal circulation in which a vascular network is formed in the inner choroidal layers with an aneurysmal bulge usually at the margin of such network. The aneurysmal bulge is clinically visible as a reddish-orange polyp-like structure.<xref ref-type="bibr" rid="article-140466.r53">[53]</xref>&#x000a0;</p>
        <p>In ICGA, even though the PCV network&#x000a0;starts getting&#x000a0;filled with the dye earlier than the retinal vessels, it gets filled slowly. Later the polyps become visible as hypercyanescent lesions. The EVEREST study on PCV used the following criteria to diagnose PCV: early focal subretinal hypercyanescence appearing within 6 minutes of ICG administration with at least one of the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>associated branching vascular network,</p>
          </list-item>
          <list-item>
            <p>pulsatile polyp,</p>
          </list-item>
          <list-item>
            <p>nodular appearance on stereoscopic view,</p>
          </list-item>
          <list-item>
            <p>hypocyanescent halo around polyp within 6 minutes,</p>
          </list-item>
          <list-item>
            <p>orange subretinal nodule on stereoscopic color fundus photo that corresponds to the polyp on ICGA, and</p>
          </list-item>
          <list-item>
            <p>massive submacular hemorrhage (minimum size of 4 disc area).<xref ref-type="bibr" rid="article-140466.r54">[54]</xref></p>
          </list-item>
        </list>
        <p>It is important to differentiate PCV from CNVM as PCV responds better with photodynamic therapy (PDT) or a combination of PDT&#x000a0;and intravitreal&#x000a0;anti-VEGF therapy rather than&#x000a0;anti-VEGF therapy alone.<xref ref-type="bibr" rid="article-140466.r54">[54]</xref><xref ref-type="bibr" rid="article-140466.r55">[55]</xref>&#x000a0;Peripheral exudative hemorrhagic chorioretinopathy (PEHCR) has been divided into two groups: with and without peripheral PCV.&#x000a0;The peripheral PCV subtype shows polyps on ICGA in eyes with PEHCR.<xref ref-type="bibr" rid="article-140466.r56">[56]</xref></p>
        <p>
<bold>Central Serous Chorioretinopathy (CSCR)</bold>
</p>
        <p>ICGA of CSCR is characterized by multifocal areas of choroidal hyperpermeability in the mid and late phases.<xref ref-type="bibr" rid="article-140466.r57">[57]</xref>&#x000a0;These areas of hyperpermeability may surround the area of leak seen on FFA, in the unaffected retina, or in the fellow eye. The early phase shows a delay in the choroidal filling. The late phase of ICGA may show persistent hypercyanescence or washout. Chronic CSCR is characterized by multifocal areas of inner choroidal hyperpermeability.&#x000a0;Identifying these areas of leaks helps in the treatment of chronic CSCR using PDT.<xref ref-type="bibr" rid="article-140466.r58">[58]</xref>&#x000a0;</p>
        <p>ICGA also helps to differentiate CSCR from PCV and helps detect underlying CNVM in CSCR.<xref ref-type="bibr" rid="article-140466.r59">[59]</xref>&#x000a0;Other ICGA features of CSCR include presumed occult serous PEDs,<xref ref-type="bibr" rid="article-140466.r60">[60]</xref>&#x000a0;delayed arterial filling of choroid and choriocapillaris, punctate hypercyanescent spots,<xref ref-type="bibr" rid="article-140466.r61">[61]</xref>&#x000a0;with choriocapillaris and venous congestion.<xref ref-type="bibr" rid="article-140466.r36">[36]</xref>&#x000a0;</p>
        <p>ICGA forms an important investigation for the recently described pachychoroid disease spectrum, including CSCR, PCV, pachychoroid pigment epitheliopathy (PPE), pachychoroid neovasculopathy (PNV), focal choroidal excavation,<xref ref-type="bibr" rid="article-140466.r62">[62]</xref>&#x000a0;and peripapillary pachychoroid syndrome (PPS).<xref ref-type="bibr" rid="article-140466.r63">[63]</xref></p>
        <p>
<bold>Retinal Arterial Macroaneurysm (RAM)</bold>
</p>
        <p>Retinal arterial macroaneurysm can present with pre-retinal, intraretinal, and subretinal hemorrhage. In case of significant pre-retinal hemorrhage, FA may not visualize the macroaneurysm due to the masking effect of the hemorrhage. But ICGA can visualize the macroaneurysm as the infrared rays can penetrate better through the hemorrhage.<xref ref-type="bibr" rid="article-140466.r64">[64]</xref></p>
        <p>
<bold>Choroidal Tumors</bold>
</p>
        <p><bold>Choroidal melanoma -&#x000a0;</bold>ICGA is superior to FA in identifying the tumor vasculature and borders. The tumor microcirculation patterns in ICGA, such as&#x000a0;parallel with cross-linking, loops, arcs with branching,&#x000a0;and networks, are associated with a higher rate of tumor growth.<xref ref-type="bibr" rid="article-140466.r65">[65]</xref></p>
        <p><bold>Choroidal hemangioma -&#x000a0;</bold>In circumscribed choroidal hemangioma, the intrinsic vascular pattern is seen 30 seconds after injection of ICG. The lesions become intensely hypercyanescent at 1 minute. In the late phases of the angiogram, the dye washes out from the lesion rapidly compared to the background choroid making the hemangioma appear hypocyanescent.<xref ref-type="bibr" rid="article-140466.r66">[66]</xref></p>
        <p>
<bold>White Dot Syndromes</bold>
</p>
        <p><bold>Birdshot chorioretinopathy&#x000a0;</bold>- In ICGA, hypocyanescent dots correspond to the cream-colored lesions in birdshot chorioretinopathy. ICGA is superior to FA in this disease as these lesions are not usually visualized in FA.<xref ref-type="bibr" rid="article-140466.r67">[67]</xref></p>
        <p><bold>Multifocal Choroiditis -&#x000a0;</bold>The white lesions in multifocal choroiditis are visualized as hypocyanescent dots in ICGA. ICGA can be used to monitor the treatment response as the number and size of these hypocyanescent areas decrease with successful treatment with systemic steroids.<xref ref-type="bibr" rid="article-140466.r68">[68]</xref></p>
        <p><bold>Multiple evanescent white dot syndrome (MEWDS)&#x000a0;</bold>- MEWDS presents with unilateral diminution of vision. It is common in young females. It has a transient and self-limiting course. ICGA reveals multiple hypocyanescent spots in the mid and late phases. These spots are more apparent in ICGA compared to FA.<xref ref-type="bibr" rid="article-140466.r69">[69]</xref></p>
        <p><bold>Serpiginous choroidopathy&#x000a0;</bold>- In serpiginous choroidopathy, ICGA reveals choroidal alterations even if there&#x000a0;is&#x000a0;no&#x000a0;clinical or FA evidence. In ICGA, the active lesions appear to be larger compared to FA. Thus it helps in the identification of active lesions. Also, choroidal activity can be present even after the cessation of retinal activity. This can be identified using ICGA.<xref ref-type="bibr" rid="article-140466.r70">[70]</xref></p>
        <p><bold>Acute posterior multifocal placoid pigment epitheliopathy (APMPPE)&#x000a0;</bold>- In acute APMPPE, ICGA reveals hypocyanescent lesions in both the early and late phases of the angiogram. This is hypothesized to be due to choroidal hypoperfusion secondary to occlusive vasculitis.<xref ref-type="bibr" rid="article-140466.r71">[71]</xref></p>
        <p><bold>Punctate inner chorioretinopathy (PIC)&#x000a0;</bold>- Hypocyanescent spots are noted in all phases of ICGA, which may be more in number than is visible on fundus photo or FFA.<xref ref-type="bibr" rid="article-140466.r72">[72]</xref><xref ref-type="bibr" rid="article-140466.r73">[73]</xref></p>
        <p><bold>Acute zonal occult outer retinopathy (AZOOR) -&#x000a0;</bold>Fundus autofluorescence shows very typical features. ICGA may be normal or may show hypocyanescence. In late-stage AZOOR, a trizonal pattern may be noted.&#x000a0;The area outside the lesion shows normal cyanescence (zone 1). The margin shows late extrachoroidal leakage (minimal) (zone 2). Zone 3 or the area inside the lesson shows hypocyanescence due to choriocapillaris atrophy.<xref ref-type="bibr" rid="article-140466.r74">[74]</xref></p>
        <p>
<bold>Chorioretinal Atrophy</bold>
</p>
        <p>In Stargardt disease, there is a complete loss of choriocapillaris ('dark atrophy' or complete absence of choriocapillaris on ICGA) whereas, in geographical atrophy secondary to age-related macular degeneration (ARMD), residual choriocapillaris are present. ICGA aids in differentiating between late-onset Stargardt disease from chorioretinal atrophy. Hypocyanescence is seen in the late phases of ICGA in the case of Stargardt disease.<xref ref-type="bibr" rid="article-140466.r75">[75]</xref>&#x000a0;In dry AMD with geographic atrophy, the areas of atrophy become isocyanescent in the late phase of ICGA.</p>
        <p>
<bold>Ocular inflammatory Diseases</bold>
</p>
        <p><bold>Sympathetic Ophthalmia:&#x000a0;</bold>ICGA shows hypocyanescent patches, some of which may become isocyanescent in the late phase.<xref ref-type="bibr" rid="article-140466.r76">[76]</xref></p>
        <p><bold>Vogt Koyanagi Harada (VKH) syndrome</bold>: The ICGA features in the acute phase include early hypercyanescence and leakage from choroidal stromal vessels, hypocyanescent spots, fuzzy large choroidal vessels, and hypercyanescence of the optic disc.<xref ref-type="bibr" rid="article-140466.r77">[77]</xref>&#x000a0;The hypocyanescent spots resolve with adequate therapy. The persistence of such ICGA lesions despite therapy may denote the presence of subclinical inflammation that may lead to sunset glow fundus and suggest the need to increase the immunosuppression in such cases.<xref ref-type="bibr" rid="article-140466.r77">[77]</xref>&#x000a0;ICGA may be used to detect subclinical recurrence of VKH syndrome.<xref ref-type="bibr" rid="article-140466.r78">[78]</xref></p>
      </sec>
      <sec id="article-140466.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The team of&#x000a0;the ophthalmologist and the assisting nurse takes consent and counsels the patient before the procedure. Pushing the ICG dye while the ophthalmologist or the technician is capturing the images,&#x000a0;monitoring the patient for any adverse reactions during the procedure is also carried out by the nursing staff. Anesthetists or critical care specialists are required&#x000a0;in cases of severe allergy and anaphylactic reaction. An interprofessional team approach helps to prevent and manage complications. It helps in carrying out ICG angiography&#x000a0;with minimal risk.</p>
      </sec>
      <sec id="article-140466.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140466&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140466">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/140466/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=140466">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-140466.s14">
        <fig id="article-140466.image.f1" position="float" orientation="portrait">
          <caption>
            <p>FA (A), ICGA (B), color fundus photo (C) and optical coherence tomography image (D) of the left eye of a patient with circumscribed choroidal hemangioma with macular edema Contributed by Sabareesh Muraleedharan,MS, Aravind eye hospital, Madurai</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CHOROIDAL__HEMANGIOMA" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-140466.s15">
        <fig id="article-140466.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Polypoidal Choroidal Vasculopathy. These images show features of a left eye with polypoidal choroidal vasculopathy through fluorescein angiography (A) and indocyanine green angiography (B). Contributed by S Muraleedharan, MS; Aravind Eye Hospital</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="PCV" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-140466.s16">
        <fig id="article-140466.image.f3" position="float" orientation="portrait">
          <caption>
            <p>FA (A) and ICGA (B) of the right eye of a patient with RAM at superotemporal arcade with vitreous hemorrhage Contributed by Sabareesh Muraleedharan,MS, Aravind eye hospital, Madurai</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="RAM" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-140466.s17">
        <fig id="article-140466.image.f4" position="float" orientation="portrait">
          <caption>
            <p>FA (A), ICGA (B) and color fundus photo (C) of the right eye of a patient with MEWDS Contributed by Sabareesh Muraleedharan,MS, Aravind eye hospital, Madurai</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MEWDS" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-140466.s18">
        <fig id="article-140466.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Color fundus photo (A), FA (B) and ICGA (C) of the right eye of a patient with RAP Contributed by Sabareesh Muraleedharan,MS, Aravind eye hospital, Madurai</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="RAP" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-140466.s19">
        <title>References</title>
        <ref id="article-140466.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Indocyanine green angiography: a perspective on use in the clinical setting.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2011</year>
            <month>May</month>
            <volume>151</volume>
            <issue>5</issue>
            <fpage>745</fpage>
            <page-range>745-751.e1</page-range>
            <pub-id pub-id-type="pmid">21501704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r2">
          <label>2</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ruia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Fluorescein Angiography</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">35015403</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dzurinko</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Gurwood</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Intravenous and indocyanine green angiography.</article-title>
            <source>Optometry</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>75</volume>
            <issue>12</issue>
            <fpage>743</fpage>
            <page-range>743-55</page-range>
            <pub-id pub-id-type="pmid">15624671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Invernizzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pellegrini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cornish</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Yi Chong Teo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cereda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chabblani</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Imaging the Choroid: From Indocyanine Green Angiography to Optical Coherence Tomography Angiography.</article-title>
            <source>Asia Pac J Ophthalmol (Phila)</source>
            <year>2020</year>
            <season>Jul-Aug</season>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>335</fpage>
            <page-range>335-348</page-range>
            <pub-id pub-id-type="pmid">32739938</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Qu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Piao</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Optical Coherence Tomography Angiography Compared with Indocyanine Green Angiography in Central Serous Chorioretinopathy.</article-title>
            <source>Sci Rep</source>
            <year>2019</year>
            <month>Apr</month>
            <day>16</day>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>6149</fpage>
            <pub-id pub-id-type="pmid">30992527</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Slakter</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Guyer</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Sorenson</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Orlock</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Indocyanine-green angiography.</article-title>
            <source>Curr Opin Ophthalmol</source>
            <year>1995</year>
            <month>Jun</month>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>25</fpage>
            <page-range>25-32</page-range>
            <pub-id pub-id-type="pmid">10151085</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Craandijk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Van Beek</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Indocyanine green fluorescence angiography of the choroid.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1976</year>
            <month>May</month>
            <volume>60</volume>
            <issue>5</issue>
            <fpage>377</fpage>
            <page-range>377-85</page-range>
            <pub-id pub-id-type="pmid">952809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wadekar</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Venkatesh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>YR</given-names>
              </name>
              <name>
                <surname>Vohra</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>An 18-year-old female with unilateral painless vision loss.</article-title>
            <source>Oman J Ophthalmol</source>
            <year>2016</year>
            <season>Sep-Dec</season>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>193</fpage>
            <pub-id pub-id-type="pmid">27843243</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Choroidal neovascular membrane in intraocular tuberculosis.</article-title>
            <source>GMS Ophthalmol Cases</source>
            <year>2017</year>
            <volume>7</volume>
            <fpage>Doc24</fpage>
            <pub-id pub-id-type="pmid">28944155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r10">
          <label>10</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Central Serous Chorioretinopathy</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">32644399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paulbuddhe</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Addya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gurnani</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Sympathetic Ophthalmia: Where Do We Currently Stand on Treatment Strategies?</article-title>
            <source>Clin Ophthalmol</source>
            <year>2021</year>
            <volume>15</volume>
            <fpage>4201</fpage>
            <page-range>4201-4218</page-range>
            <pub-id pub-id-type="pmid">34707340</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayreh</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>THE OPHTHALMIC ARTERY: III. BRANCHES.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1962</year>
            <month>Apr</month>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>212</fpage>
            <page-range>212-47</page-range>
            <pub-id pub-id-type="pmid">18170772</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayreh</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>In vivo choroidal circulation and its watershed zones.</article-title>
            <source>Eye (Lond)</source>
            <year>1990</year>
            <volume>4 ( Pt 2)</volume>
            <fpage>273</fpage>
            <page-range>273-89</page-range>
            <pub-id pub-id-type="pmid">2199236</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Borrelli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sarraf</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Freund</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Sadda</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>OCT angiography and evaluation of the choroid and choroidal vascular disorders.</article-title>
            <source>Prog Retin Eye Res</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>67</volume>
            <fpage>30</fpage>
            <page-range>30-55</page-range>
            <pub-id pub-id-type="pmid">30059755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zouache</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Eames</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Klettner</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Luthert</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Form, shape and function: segmented blood flow in the choriocapillaris.</article-title>
            <source>Sci Rep</source>
            <year>2016</year>
            <month>Oct</month>
            <day>25</day>
            <volume>6</volume>
            <fpage>35754</fpage>
            <pub-id pub-id-type="pmid">27779198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirata</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nishiwaki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Miura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ieki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Honda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yumikake</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sugino</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Okazaki</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Analysis of choriocapillaris flow patterns by continuous laser-targeted angiography in monkeys.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>45</volume>
            <issue>6</issue>
            <fpage>1954</fpage>
            <page-range>1954-62</page-range>
            <pub-id pub-id-type="pmid">15161863</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayreh</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Segmental nature of the choroidal vasculature.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1975</year>
            <month>Nov</month>
            <volume>59</volume>
            <issue>11</issue>
            <fpage>631</fpage>
            <page-range>631-48</page-range>
            <pub-id pub-id-type="pmid">812547</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nickla</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Wallman</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The multifunctional choroid.</article-title>
            <source>Prog Retin Eye Res</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>144</fpage>
            <page-range>144-68</page-range>
            <pub-id pub-id-type="pmid">20044062</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'goshi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Serup</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Safety of sodium fluorescein for in vivo study of skin.</article-title>
            <source>Skin Res Technol</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>155</fpage>
            <page-range>155-61</page-range>
            <pub-id pub-id-type="pmid">16827689</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grayson</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Laties</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Ocular localization of sodium fluorescein. Effects of administration in rabbit and monkey.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1971</year>
            <month>May</month>
            <volume>85</volume>
            <issue>5</issue>
            <fpage>600</fpage>
            <page-range>600-3 passim</page-range>
            <pub-id pub-id-type="pmid">4996602</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ra</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Baek</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Choroidal vascular densities of macular disease on ultra-widefield indocyanine green angiography.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>258</volume>
            <issue>9</issue>
            <fpage>1921</fpage>
            <page-range>1921-1929</page-range>
            <pub-id pub-id-type="pmid">32494872</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheung</surname>
                <given-names>CMG</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>TYY</given-names>
              </name>
              <name>
                <surname>Teo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ruamviboonsuk</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Gomi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Kokame</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Jordan-Yu</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Corvi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Invernizzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ogura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Chhablani</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chakravarthy</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Sadda</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Staurenghi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>WK</given-names>
              </name>
            </person-group>
            <article-title>Polypoidal Choroidal Vasculopathy: Consensus Nomenclature and Non-Indocyanine Green Angiograph Diagnostic Criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup.</article-title>
            <source>Ophthalmology</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>128</volume>
            <issue>3</issue>
            <fpage>443</fpage>
            <page-range>443-452</page-range>
            <pub-id pub-id-type="pmid">32795496</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parravano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pilotto</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Musicco</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Varano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Introini</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Staurenghi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Menchini</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Virgili</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Reproducibility of fluorescein and indocyanine green angiographic assessment for RAP diagnosis: a multicenter study.</article-title>
            <source>Eur J Ophthalmol</source>
            <year>2012</year>
            <season>Jul-Aug</season>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>598</fpage>
            <page-range>598-606</page-range>
            <pub-id pub-id-type="pmid">22139618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r24">
          <label>24</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Singh</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Retinal Macroaneurysm</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">35015432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r25">
          <label>25</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Mount</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Kaufman</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <chapter-title>White Dot Syndromes</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>3</month>
            <day>13</day>
            <pub-id pub-id-type="pmid">32491777</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moshfeghi</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Ferrone</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Indocyanine green angiography findings in sympathetic ophthalmia.</article-title>
            <source>Ophthalmic Surg Lasers Imaging</source>
            <year>2005</year>
            <season>Mar-Apr</season>
            <volume>36</volume>
            <issue>2</issue>
            <fpage>163</fpage>
            <page-range>163-6</page-range>
            <pub-id pub-id-type="pmid">15792321</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agrawal</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Biswas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gunasekaran</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Indocyanine green angiography in posterior uveitis.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>61</volume>
            <issue>4</issue>
            <fpage>148</fpage>
            <page-range>148-59</page-range>
            <pub-id pub-id-type="pmid">23685486</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ma</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>JX</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Hang</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Intraoperative indocyanine green angiography in intracranial aneurysm surgery: Microsurgical clipping and revascularization.</article-title>
            <source>Clin Neurol Neurosurg</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>111</volume>
            <issue>10</issue>
            <fpage>840</fpage>
            <page-range>840-6</page-range>
            <pub-id pub-id-type="pmid">19747765</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hardesty</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Thind</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zabramski</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Spetzler</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Nakaji</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Safety, efficacy, and cost of intraoperative indocyanine green angiography compared to intraoperative catheter angiography in cerebral aneurysm surgery.</article-title>
            <source>J Clin Neurosci</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>21</volume>
            <issue>8</issue>
            <fpage>1377</fpage>
            <page-range>1377-82</page-range>
            <pub-id pub-id-type="pmid">24736193</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bischoff</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Flower</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Ten years experience with choroidal angiography using indocyanine green dye: a new routine examination or an epilogue?</article-title>
            <source>Doc Ophthalmol</source>
            <year>1985</year>
            <month>Sep</month>
            <day>30</day>
            <volume>60</volume>
            <issue>3</issue>
            <fpage>235</fpage>
            <page-range>235-91</page-range>
            <pub-id pub-id-type="pmid">2414083</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Costa</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Orlock</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Freund</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Spaide</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>NE</given-names>
              </name>
            </person-group>
            <article-title>Retinal-choroidal indocyanine green dye clearance and liver dysfunction.</article-title>
            <source>Retina</source>
            <year>2003</year>
            <month>Aug</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>557</fpage>
            <page-range>557-61</page-range>
            <pub-id pub-id-type="pmid">12972775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fineman</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Maguire</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Fineman</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Benson</surname>
                <given-names>WE</given-names>
              </name>
            </person-group>
            <article-title>Safety of indocyanine green angiography during pregnancy: a survey of the retina, macula, and vitreous societies.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2001</year>
            <month>Mar</month>
            <volume>119</volume>
            <issue>3</issue>
            <fpage>353</fpage>
            <page-range>353-5</page-range>
            <pub-id pub-id-type="pmid">11231768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hassenstein</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Clinical use and research applications of Heidelberg retinal angiography and spectral-domain optical coherence tomography - a review.</article-title>
            <source>Clin Exp Ophthalmol</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>130</fpage>
            <page-range>130-43</page-range>
            <pub-id pub-id-type="pmid">19338610</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheung</surname>
                <given-names>CMG</given-names>
              </name>
              <name>
                <surname>Teo</surname>
                <given-names>KYC</given-names>
              </name>
              <name>
                <surname>Tun</surname>
                <given-names>SBB</given-names>
              </name>
              <name>
                <surname>Busoy</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Barathi</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Spaide</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>Correlation of choriocapillaris hemodynamic data from dynamic indocyanine green and optical coherence tomography angiography.</article-title>
            <source>Sci Rep</source>
            <year>2021</year>
            <month>Aug</month>
            <day>02</day>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>15580</fpage>
            <pub-id pub-id-type="pmid">34341447</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stanga</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update.</article-title>
            <source>Ophthalmology</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>110</volume>
            <issue>1</issue>
            <fpage>15</fpage>
            <page-range>15-21; quiz 22-3</page-range>
            <pub-id pub-id-type="pmid">12511340</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pr&#x000fc;nte</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Flammer</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Choroidal capillary and venous congestion in central serous chorioretinopathy.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1996</year>
            <month>Jan</month>
            <volume>121</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <page-range>26-34</page-range>
            <pub-id pub-id-type="pmid">8554078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hope-Ross</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Gragoudas</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Guyer</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Slakter</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Sorenson</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Krupsky</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Orlock</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Puliafito</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Adverse reactions due to indocyanine green.</article-title>
            <source>Ophthalmology</source>
            <year>1994</year>
            <month>Mar</month>
            <volume>101</volume>
            <issue>3</issue>
            <fpage>529</fpage>
            <page-range>529-33</page-range>
            <pub-id pub-id-type="pmid">8127574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haddad</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Coscas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Soubrane</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Eligibility for treatment and angiographic features at the early stage of exudative age related macular degeneration.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>86</volume>
            <issue>6</issue>
            <fpage>663</fpage>
            <page-range>663-9</page-range>
            <pub-id pub-id-type="pmid">12034690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Freund</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Sorenson</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Age-related macular degeneration and choroidal neovascularization.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1993</year>
            <month>Jun</month>
            <day>15</day>
            <volume>115</volume>
            <issue>6</issue>
            <fpage>786</fpage>
            <page-range>786-91</page-range>
            <pub-id pub-id-type="pmid">7685148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guyer</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Slakter</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Sorenson</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Hanutsaha</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Spaide</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Hirschfeld</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Orlock</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Classification of choroidal neovascularization by digital indocyanine green videoangiography.</article-title>
            <source>Ophthalmology</source>
            <year>1996</year>
            <month>Dec</month>
            <volume>103</volume>
            <issue>12</issue>
            <fpage>2054</fpage>
            <page-range>2054-60</page-range>
            <pub-id pub-id-type="pmid">9003339</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Hope-Ross</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Slakter</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Guyer</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Sorenson</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Sperber</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Freund</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Orlock</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Analysis of vascularized pigment epithelial detachments using indocyanine green videoangiography.</article-title>
            <source>Retina</source>
            <year>1994</year>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>99</fpage>
            <page-range>99-113</page-range>
            <pub-id pub-id-type="pmid">7518607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gass</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Serous retinal pigment epithelial detachment with a notch. A sign of occult choroidal neovascularization.</article-title>
            <source>Retina</source>
            <year>1984</year>
            <season>Fall-Winter</season>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>205</fpage>
            <page-range>205-20</page-range>
            <pub-id pub-id-type="pmid">6085179</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Byeon</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Identification of Underlying Causes of Spontaneous Submacular Hemorrhage by Indocyanine Green Angiography.</article-title>
            <source>Ophthalmologica</source>
            <year>2015</year>
            <volume>233</volume>
            <issue>3-4</issue>
            <fpage>146</fpage>
            <page-range>146-54</page-range>
            <pub-id pub-id-type="pmid">25833061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hlushchuk</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Baum</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Gruber</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Djonov</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>The synergistic action of a VEGF-receptor tyrosine-kinase inhibitor and a sensitizing PDGF-receptor blocker depends upon the stage of vascular maturation.</article-title>
            <source>Microcirculation</source>
            <year>2007</year>
            <season>Nov-Dec</season>
            <volume>14</volume>
            <issue>8</issue>
            <fpage>813</fpage>
            <page-range>813-25</page-range>
            <pub-id pub-id-type="pmid">17907017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Massacesi</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Sacchi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bergamini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bottoni</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>The prevalence of retinal angiomatous proliferation in age-related macular degeneration with occult choroidal neovascularization.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>246</volume>
            <issue>1</issue>
            <fpage>89</fpage>
            <page-range>89-92</page-range>
            <pub-id pub-id-type="pmid">17653567</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuhn</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Meunier</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Soubrane</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Coscas</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Imaging of chorioretinal anastomoses in vascularized retinal pigment epithelium detachments.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1995</year>
            <month>Nov</month>
            <volume>113</volume>
            <issue>11</issue>
            <fpage>1392</fpage>
            <page-range>1392-8</page-range>
            <pub-id pub-id-type="pmid">7487600</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bressler</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Retinal anastomosis to choroidal neovascularization: a bum rap for a difficult disease.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>123</volume>
            <issue>12</issue>
            <fpage>1741</fpage>
            <page-range>1741-3</page-range>
            <pub-id pub-id-type="pmid">16344449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghazi</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Knape</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Kirk</surname>
                <given-names>TQ</given-names>
              </name>
              <name>
                <surname>Tiedeman</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Conway</surname>
                <given-names>BP</given-names>
              </name>
            </person-group>
            <article-title>Intravitreal bevacizumab (avastin) treatment of retinal angiomatous proliferation.</article-title>
            <source>Retina</source>
            <year>2008</year>
            <month>May</month>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>689</fpage>
            <page-range>689-95</page-range>
            <pub-id pub-id-type="pmid">18463511</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bottoni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Massacesi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cigada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Viola</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Musicco</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Staurenghi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>123</volume>
            <issue>12</issue>
            <fpage>1644</fpage>
            <page-range>1644-50</page-range>
            <pub-id pub-id-type="pmid">16344434</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rouvas</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Papakostas</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Vavvas</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vergados</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Moschos</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Kotsolis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ladas</surname>
                <given-names>ID</given-names>
              </name>
            </person-group>
            <article-title>Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study.</article-title>
            <source>Retina</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>536</fpage>
            <page-range>536-44</page-range>
            <pub-id pub-id-type="pmid">19190547</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saito</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shiragami</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shiraga</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iida</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>149</volume>
            <issue>3</issue>
            <fpage>472</fpage>
            <page-range>472-81.e1</page-range>
            <pub-id pub-id-type="pmid">20053392</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koh</surname>
                <given-names>AH</given-names>
              </name>
              <collab>Expert PCV Panel</collab>
              <name>
                <surname>Chen</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Giridhar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Iida</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yuk Yau Lai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Han Lim</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ruamviboonsuk</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yuzawa</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment.</article-title>
            <source>Retina</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>686</fpage>
            <page-range>686-716</page-range>
            <pub-id pub-id-type="pmid">23455233</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Sorenson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Spaide</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Lipson</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Idiopathic polypoidal choroidal vasculopathy (IPCV).</article-title>
            <source>Retina</source>
            <year>1990</year>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-8</page-range>
            <pub-id pub-id-type="pmid">1693009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Hashad</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Pilz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ruamviboonsuk</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tokaji</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Weisberger</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>TH</given-names>
              </name>
            </person-group>
            <article-title>EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy.</article-title>
            <source>Retina</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>32</volume>
            <issue>8</issue>
            <fpage>1453</fpage>
            <page-range>1453-64</page-range>
            <pub-id pub-id-type="pmid">22426346</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lai</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Luk</surname>
                <given-names>FO</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2008</year>
            <month>May</month>
            <volume>92</volume>
            <issue>5</issue>
            <fpage>661</fpage>
            <page-range>661-6</page-range>
            <pub-id pub-id-type="pmid">18356265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldman</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Freund</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>McCannel</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Sarraf</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Peripheral polypoidal choroidal vasculopathy as a cause of peripheral exudative hemorrhagic chorioretinopathy: a report of 10 eyes.</article-title>
            <source>Retina</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <page-range>48-55</page-range>
            <pub-id pub-id-type="pmid">22836900</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spaide</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Haas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Campeas</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Guyer</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Slakter</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Sorenson</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Orlock</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Indocyanine green videoangiography of older patients with central serous chorioretinopathy.</article-title>
            <source>Retina</source>
            <year>1996</year>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>203</fpage>
            <page-range>203-13</page-range>
            <pub-id pub-id-type="pmid">8789858</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Slakter</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Spaide</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Klancnik</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Aizman</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study.</article-title>
            <source>Retina</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>23</volume>
            <issue>3</issue>
            <fpage>288</fpage>
            <page-range>288-98</page-range>
            <pub-id pub-id-type="pmid">12824827</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Freund</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Goldbaum</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Scassellati-Sforzolini</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Guyer</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Spaide</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Maberley</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Slakter</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Sorenson</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Orlock</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy.</article-title>
            <source>Ophthalmology</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>107</volume>
            <issue>4</issue>
            <fpage>767</fpage>
            <page-range>767-77</page-range>
            <pub-id pub-id-type="pmid">10768341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guyer</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Slakter</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Sorenson</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Orlock</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Digital indocyanine green videoangiography of central serous chorioretinopathy.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1994</year>
            <month>Aug</month>
            <volume>112</volume>
            <issue>8</issue>
            <fpage>1057</fpage>
            <page-range>1057-62</page-range>
            <pub-id pub-id-type="pmid">8053819</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsujikawa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ojima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yamashiro</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ooto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tamura</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nakagawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yoshimura</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography.</article-title>
            <source>Retina</source>
            <year>2010</year>
            <month>May</month>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>801</fpage>
            <page-range>801-9</page-range>
            <pub-id pub-id-type="pmid">20094008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chung</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Byeon</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Freund</surname>
                <given-names>KB</given-names>
              </name>
            </person-group>
            <article-title>FOCAL CHOROIDAL EXCAVATION AND ITS ASSOCIATION WITH PACHYCHOROID SPECTRUM DISORDERS: A Review of the Literature and Multimodal Imaging Findings.</article-title>
            <source>Retina</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>199</fpage>
            <page-range>199-221</page-range>
            <pub-id pub-id-type="pmid">27749784</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheung</surname>
                <given-names>CMG</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Koizumi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Dansingani</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>TYY</given-names>
              </name>
              <name>
                <surname>Freund</surname>
                <given-names>KB</given-names>
              </name>
            </person-group>
            <article-title>Pachychoroid disease.</article-title>
            <source>Eye (Lond)</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>14</fpage>
            <page-range>14-33</page-range>
            <pub-id pub-id-type="pmid">29995841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schneider</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Kreissig</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Indocyanine green videoangiography of hemorrhagic retinal arterial macroaneurysms.</article-title>
            <source>Ophthalmologica</source>
            <year>1997</year>
            <volume>211</volume>
            <issue>2</issue>
            <fpage>115</fpage>
            <page-range>115-8</page-range>
            <pub-id pub-id-type="pmid">9097320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mueller</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Freeman</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Schaller</surname>
                <given-names>UC</given-names>
              </name>
              <name>
                <surname>Kampik</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Folberg</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Complex microcirculation patterns detected by confocal indocyanine green angiography predict time to growth of small choroidal melanocytic tumors: MuSIC Report II.</article-title>
            <source>Ophthalmology</source>
            <year>2002</year>
            <month>Dec</month>
            <volume>109</volume>
            <issue>12</issue>
            <fpage>2207</fpage>
            <page-range>2207-14</page-range>
            <pub-id pub-id-type="pmid">12466160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arevalo</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Hykin</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>De Potter</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Circumscribed choroidal hemangioma: characteristic features with indocyanine green videoangiography.</article-title>
            <source>Ophthalmology</source>
            <year>2000</year>
            <month>Feb</month>
            <volume>107</volume>
            <issue>2</issue>
            <fpage>344</fpage>
            <page-range>344-50</page-range>
            <pub-id pub-id-type="pmid">10690837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Howe</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Stanford</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Choroidal abnormalities in birdshot chorioretinopathy: an indocyanine green angiography study.</article-title>
            <source>Eye (Lond)</source>
            <year>1997</year>
            <volume>11 ( Pt 4)</volume>
            <fpage>554</fpage>
            <page-range>554-9</page-range>
            <pub-id pub-id-type="pmid">9425423</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Slakter</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Giovannini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Scassellati-Sforzolini</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Guyer</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Sorenson</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Spaide</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Orlock</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Indocyanine green angiography of multifocal choroiditis.</article-title>
            <source>Ophthalmology</source>
            <year>1997</year>
            <month>Nov</month>
            <volume>104</volume>
            <issue>11</issue>
            <fpage>1813</fpage>
            <page-range>1813-9</page-range>
            <pub-id pub-id-type="pmid">9373111</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dell'omo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Marino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Konstantopoulou</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pavesio</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Relationship between different fluorescein and indocyanine green angiography features in multiple evanescent white dot syndrome.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>94</volume>
            <issue>1</issue>
            <fpage>59</fpage>
            <page-range>59-63</page-range>
            <pub-id pub-id-type="pmid">19692364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giovannini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mariotti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ripa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Scassellati-Sforzolini</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Indocyanine green angiographic findings in serpiginous choroidopathy.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1996</year>
            <month>Jun</month>
            <volume>80</volume>
            <issue>6</issue>
            <fpage>536</fpage>
            <page-range>536-40</page-range>
            <pub-id pub-id-type="pmid">8759265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Howe</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Woon</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Fitzke</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bhandari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Choroidal hypoperfusion in acute posterior multifocal placoid pigment epitheliopathy. An indocyanine green angiography study.</article-title>
            <source>Ophthalmology</source>
            <year>1995</year>
            <month>May</month>
            <volume>102</volume>
            <issue>5</issue>
            <fpage>790</fpage>
            <page-range>790-8</page-range>
            <pub-id pub-id-type="pmid">7777278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tiffin</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Maini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Roxburgh</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Ellingford</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Indocyanine green angiography in a case of punctate inner choroidopathy.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1996</year>
            <month>Jan</month>
            <volume>80</volume>
            <issue>1</issue>
            <fpage>90</fpage>
            <page-range>90-1</page-range>
            <pub-id pub-id-type="pmid">8664243</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shneck</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Klemperer</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lifshitz</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Punctate inner choroidopathy: resolution after oral steroid treatment and review of the literature.</article-title>
            <source>Can J Ophthalmol</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>40</volume>
            <issue>5</issue>
            <fpage>605</fpage>
            <page-range>605-8</page-range>
            <pub-id pub-id-type="pmid">16391624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mrejen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gallego-Pinazo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jampol</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Acute zonal occult outer retinopathy: a classification based on multimodal imaging.</article-title>
            <source>JAMA Ophthalmol</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>132</volume>
            <issue>9</issue>
            <fpage>1089</fpage>
            <page-range>1089-98</page-range>
            <pub-id pub-id-type="pmid">24945598</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pellegrini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Peroglio Deiro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bottoni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Staurenghi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The dark atrophy with indocyanine green angiography in Stargardt disease.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2012</year>
            <month>Jun</month>
            <day>26</day>
            <volume>53</volume>
            <issue>7</issue>
            <fpage>3999</fpage>
            <page-range>3999-4004</page-range>
            <pub-id pub-id-type="pmid">22589445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bernasconi</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Auer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zografos</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Herbort</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>Indocyanine green angiographic findings in sympathetic ophthalmia.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>1998</year>
            <month>Aug</month>
            <volume>236</volume>
            <issue>8</issue>
            <fpage>635</fpage>
            <page-range>635-8</page-range>
            <pub-id pub-id-type="pmid">9717662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herbort</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Mantovani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bouchenaki</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up.</article-title>
            <source>Int Ophthalmol</source>
            <year>2007</year>
            <season>Apr-Jun</season>
            <volume>27</volume>
            <issue>2-3</issue>
            <fpage>173</fpage>
            <page-range>173-82</page-range>
            <pub-id pub-id-type="pmid">17457515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140466.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bouchenaki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Herbort</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>Indocyanine green angiography guided management of vogt-koyanagi-harada disease.</article-title>
            <source>J Ophthalmic Vis Res</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>241</fpage>
            <page-range>241-8</page-range>
            <pub-id pub-id-type="pmid">22454746</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
